￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Efficacy and Safety of Crizotinib (Xalkori) in Patients with Lung Cancer

2025-10-19 11:44:20

Check Details
Will larotrectinib be included in the national medical insurance in China in 2021?

2025-10-19 11:44:20

Check Details
Where can I buy larotrectinib in China? How much does a box cost?

2025-10-19 11:44:20

Check Details
Can the broad-spectrum anticancer drug larotrectinib be reimbursed by medical insurance?

2025-10-19 11:44:20

Check Details
Can cabozantinib (XL184) improve quality of life in metastatic RCC?

2025-10-19 11:44:20

Check Details
Data on the efficacy of larotrectinib in the treatment of NTRK-positive lung cancer

2025-10-19 11:44:20

Check Details
Precautions for using larotinib in patients with lung cancer

2025-10-19 11:44:20

Check Details
The cost of larotrectinib treatment for lung cancer _ Kanghule

2025-10-19 11:44:20

Check Details
Is the NTRK inhibitor larotrectinib covered by medical insurance?

2025-10-19 11:44:20

Check Details
Larotrectinib brings new options to patients with NRTK-positive lung cancer

2025-10-19 11:44:20

Check Details
How long can patients with liver cancer live after regorafenib treatment?

2025-10-19 11:44:20

Check Details
Larotinib is a broad-spectrum anti-tumor drug applied to the NTRK target_ Kanghule

2025-10-19 11:44:20

Check Details
Category
相关知识